Price T Rowe Associates Inc Adma Biologics, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,100,638 shares of ADMA stock, worth $33.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100,638
Previous 2,100,134
0.02%
Holding current value
$33.8 Million
Previous $42 Million
14.18%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ADMA
# of Institutions
334Shares Held
188MCall Options Held
1.52MPut Options Held
756K-
Black Rock Inc. New York, NY18.6MShares$300 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$293 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$239 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$182 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$89 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.16B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...